Who is sponsoring NCT03229759?

NCT03229759 is sponsored by Becton, Dickinson and Company.

What condition does NCT03229759 study?

NCT03229759 studies Preoperative Skin Preparation.

Is NCT03229759 still recruiting?

NCT03229759 is currently completed. Last updated 23 April 2021.

Are results published for NCT03229759?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-04-23 · How we verify

NCT03229759

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Completed Phase 2 Results posted Last updated 23 April 2021

What this trial tests

Phase 2 trial testing Octenidine Dihydrocloride in aqueous solution in Preoperative Skin Preparation in 99 participants. Completed in 4 August 2017.

Timeline

21 June 2017

Primary endpoint
4 August 2017

4 August 2017

Quick facts

Lead sponsor	Becton, Dickinson and Company
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	99
Start date	21 June 2017
Primary completion	4 August 2017
Estimated completion	4 August 2017
Sites	1 location across United States

Drugs / interventions tested

Octenidine Dihydrocloride in aqueous solution — full drug profile →
Vehicle Control — full drug profile →
Saline Control — full drug profile →

Conditions studied

Preoperative Skin Preparation — all drugs for Preoperative Skin Preparation →

Sponsor

Becton, Dickinson and Company — full company profile →

Who can join

18 and older, any sex, with Preoperative Skin Preparation. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Bacterial Count at 10 Minutes Post Application Primary · 10 minutes after application of test product

Abdomen- Baseline

Group	Value	95% CI
Investigational Product	3.55	± 0.40
Saline Control	3.61	± 0.41
Vehicle Control	3.66	± 0.40

Abdomen- 10 minutes

Group	Value	95% CI
Investigational Product	1.19	± 1.28
Saline Control	2.64	± 0.58
Vehicle Control	2.56	± 0.97

Groin- Baseline

Group	Value	95% CI
Investigational Product	5.95	± 0.60
Saline Control	6.07	± 0.53
Vehicle Control	5.89	± 0.47

Groin- 10 minutes

Group	Value	95% CI
Investigational Product	2.98	± 1.14
Saline Control	4.90	± 0.56
Vehicle Control	4.25	± 0.68

Sponsor's own description

Healthy volunteers will receive treatment to two body locations with the investigational product and placebo and the antimicrobial effectiveness of each treatment will be measured.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Becton, Dickinson and Company trials

Trials by the same sponsor.

NCT06632509 — BD SiteRite(TM) 9 Ultrasound System - Clinical Study · completed
NCT06632496 — BD Prevue(TM) II Peripheral Vascular Access System With Cue(TM) Needle Tracking Technology Clinical Study · completed
NCT06604026 — Investigational Study With the BD PosiFlush™ SafeScrub on NADs · NA · recruiting
NCT06426121 — Clinical Validation of BACTEC™ Plus Aerobic/F Culture Vials Compared With Equivalent Product · completed
NCT05953363 — Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03229759 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Becton, Dickinson and Company
Last refreshed: 23 April 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03229759.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing